Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
8582 participants
OBSERVATIONAL
2000-01-01
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
There is a lack of current population based and real world data on sex and age differences in gastric cancer care. Analyses of sex differences are primarily originate from Asia or focusing on older cohorts. In the Netherlands, Kalff et al. conducted a study with patients with gastric adenocarcinoma (n=2 072) registered in the Dutch Upper GI Cancer Audit between 2011 and 2016. In this study, patients without metastatic gastric cancer and with an elective surgery were included.
To close this sex and age data gap for patients including those with UICC IV stage and without surgery, the aim of our study was to analyze the sex and age differences in clinicopathological features and staging in gastric adenocarcinoma with cancer registry data from the Federal State of Brandenburg from 2000 to 2020.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gastric Cancer Surgery in Elderly Patients
NCT03777540
Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal Cancer
NCT05652348
Cremona Population-Based Gastric Tumors Registry
NCT01662739
Quality of Life in RECTal Cancer - a Prospective Multicenter Cohort Study
NCT01477229
Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer
NCT04180761
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
sex
Gastrectomy+ chemotherapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gastrectomy+ chemotherapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Margarete-Ammon-Stiftung
UNKNOWN
Medizinische Hochschule Brandenburg Theodor Fontane
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ulrike Weber
MSc.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EpiGaCa
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.